SCHEMBL7779654

SCHEMBL7779654

NS(=O)(=O)c1ccc(-c2n[nH]c(C(F)(F)F)c2-c2ccc(Cl)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 1/20 0.60
GYS1 P13807 1/20 0.56
PTGS2 P35354 9/20 0.47
PTGS1 P23219 7/20 0.47
TTK P33981 1/20 0.47
CA12 O43570 2/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
CA9 Q16790 2/20 0.46
CA3 P07451 1/20 0.46
CA4 P22748 1/20 0.46
CA6 P23280 1/20 0.46
CA5A P35218 1/20 0.46
CA7 P43166 1/20 0.46
CA13 Q8N1Q1 1/20 0.46
CA14 Q9ULX7 1/20 0.46
CA5B Q9Y2D0 1/20 0.46
PDPK1 O15530 1/20 0.46
ALOX5AP P20292 1/20 0.45
MAP2K7 O14733 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7780001 0.91 LRRK2 (0.51) LRRK2GYS1PTGS2PTGS1TTK
SCHEMBL7780727 0.90 LRRK2 (0.50) LRRK2GYS1PTGS2PTGS1TTK
SCHEMBL7773014 0.88 LRRK2 (0.61) LRRK2GYS1PTGS2PTGS1TTK
SCHEMBL7773326 0.88 LRRK2 (0.68) LRRK2GYS1PTGS2PTGS1TTK
SCHEMBL7773215 0.87 LRRK2 (0.77) LRRK2GYS1PTGS2CA1CA2
SCHEMBL7777620 0.87 LRRK2 (0.60) LRRK2GYS1PTGS2PTGS1CA12
SCHEMBL7779954 0.87 LRRK2 (0.60) LRRK2GYS1PTGS2PTGS1CA12
SCHEMBL8628027 0.87 GYS1 (0.53) LRRK2GYS1PTGS2PTGS1
SCHEMBL7778049 0.87 LRRK2 (0.64) LRRK2GYS1PTGS2PTGS1TTK
SCHEMBL7780586 0.86 LRRK2 (0.52) LRRK2GYS1PTGS2PTGS1TTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed